Gene- and Variant-Specific Efficacy of Serum/Glucocorticoid-Regulated Kinase 1 Inhibition in Long QT Syndrome Types 1 and 2

Scientists investigated whether serum/glucocorticoid-regulated kinase 1 could similarly shorten action potential duration in long QT syndrome types 1 and 2.